{"version":"1.0","provider_name":"BIOENGINEER.ORG","provider_url":"https:\/\/bioengineer.org","author_name":"BIOENGINEER.ORG","author_url":"https:\/\/bioengineer.org","title":"Strategy overcomes EZH2 inhibitor resistance in SMARCB1 mutated cancer","type":"rich","width":600,"height":338,"html":"
Strategy overcomes EZH2 inhibitor resistance in SMARCB1 mutated cancer<\/a><\/blockquote>